MarkNtel Advisors Predicts Amyotrophic Lateral Sclerosis Treatment Market to Surge to USD 0.97 billion by 2030 at 5.1% CAGR

Business Feb 25, 2025 22 Add to Reading List

Similar Blog Sites

Market Overview:

MarkNtel Advisors has released a new report that highlights the strong growth trajectory of the Amyotrophic Lateral Sclerosis Treatment Market, The Global Amyotrophic Lateral Sclerosis Treatment Market size was valued at around USD 0.72 billion in 2024 and is projected to reach USD 0.97 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.1% during the forecast period, i.e., 2025-30. The report provides valuable insights into the drivers, trends, and challenges shaping the future of the Amyotrophic Lateral Sclerosis Treatment Market. It offers an in-depth look at the key players, geographical performance, and the segments leading the charge in market share.

Industry Outlook & Forecasts:

Forecast Period: 2025-2030
Market Size in 2024: USD 0.72 billion
CAGR (2025-2030): 5.1%

Request for a Free PDF Sample of the Report – https://www.marknteladvisors.com/query/request-sample/amyotrophic-lateral-sclerosis-treatment-market.html

Global Amyotrophic Lateral Sclerosis Treatment Market Segmentation Breakdown:

By Disease Type
- Sporadic ALS- Market Size & Forecast 2020-2030, USD Million
- Familial ALS- Market Size & Forecast 2020-2030, USD Million
By Treatment
- Medication- Market Size & Forecast 2020-2030, USD Million
  - Riluzole- Market Size & Forecast 2020-2030, USD Million
  - Edaravone- Market Size & Forecast 2020-2030, USD Million
  - Nuedexta- Market Size & Forecast 2020-2030, USD Million
  - Others
- Stem Cell Therapy- Market Size & Forecast 2020-2030, USD Million
- Others
By Distribution Channel
- Hospital Pharmacies- Market Size & Forecast 2020-2030, USD Million
- Retail Pharmacies- Market Size & Forecast 2020-2030, USD Million
- Others

Out of them, hospital pharmacies lead the Global Amyotrophic Lateral Sclerosis Treatment Market. They hold approximately 58.4% share of the total market value.

By Route of Administration
- Oral- Market Size & Forecast 2020-2030, USD Million
- Parenteral-Market Size & Forecast 2020-2030, USD Million
By End User
- Hospitals- Market Size & Forecast 2020-2030, USD Million
- Rehabilitation Centers- Market Size & Forecast 2020-2030, USD Million
- Specialty Clinics-Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million

Out of them, the hospital segment leads the Global Amyotrophic Lateral Sclerosis Treatment Market. It holds approx. 38% of the global market.

Geographical Growth Insights:

By Region

North America
South America
Europe
The Middle East & Africa
Asia-Pacific

Out of them, North America dominates the Global Amyotrophic Lateral Sclerosis Treatment Market. It holds approximately 55% share of the total market.

MarkNtel Advisors Highlights Key Market Drivers for Amyotrophic Lateral Sclerosis Treatment Market:

Growing Prevalence of Amyotrophic Lateral Sclerosis – The rising cases of amyotrophic lateral sclerosis worldwide are one of the main factors that drive the market for this neurodegenerative condition. The disease is majorly growing in the North American region more likely to affect Whites and non-Hispanics. It is anticipated that the prevalence of amyotrophic lateral sclerosis will slightly increase as a result of the aging population, early diagnosis, and greater global awareness. Approximately 5,000 cases of amyotrophic lateral sclerosis are diagnosed every year in the US. Although it is a rare disease still the global prevalence rate of ALS is around 4–6 cases per 100,000 individuals. Furthermore, males have a higher prevalence than females comparatively but in old age, they are equally likely to be diagnosed with ALS. Sporadic ALS is making up to 90-95% of the total cases globally. Thus, the prevalence of ALS will continue to drive market growth during the forecast period.

A Comprehensive Analysis of Leading Companies in Global Amyotrophic Lateral Sclerosis Treatment Market

Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Group Corporation), Biogen, BrainStorm Cell Limited, Amylyx Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Sanofi, Otsuka Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd, AB Science, Sun Pharmaceutical Industries Ltd., Orion Corporation, CORESTEMCHEMON Inc., and others

Explore More About This Research Report @ https://www.marknteladvisors.com/research-library/amyotrophic-lateral-sclerosis-treatment-market.html

Global Amyotrophic Lateral Sclerosis Treatment Industry Recent Development:

February 2024: Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Group Corporation) launched Radicava for the treatment of ALS in Brazil at a local subsidiary of Daiichi Sankyo Company, Limited.
April 2023: Biogen received approval from the European Commission for QALSODY (tofersen) Therapy that treats SOD1-ALS. It is the third targeted drug that has been approved for the treatment of ALS

What are the growth Opportunity driving the Global Amyotrophic Lateral Sclerosis Treatment Market?

Pipeline and Drug Therapies – Gene therapies and regenerative medicine are gaining more attention from businesses and academic institutions which could lead to new treatment options and new opportunities for market growth. With encouraging results, medications that target SOD1 mutation accounting for about 2% of ALS cases, are currently in different clinical stages. Many potential treatments are under the clinical trials pipeline before seeking approval from the FDA.

More than 160 medications that address various aspects of the disease and span various stages of clinical trials were in the ALS pipeline by the end of 2023. Additionally, in 2023 the FDA approved seven additional medications to treat ALS. To introduce effective treatments to the market, several businesses including Mitsubishi Tanabe Pharma Corporation and Biogen are pursuing these opportunities.

“Report Delivery Format: Market research reports from MarkNtel Advisors are available in PDF, Excel, and PowerPoint formats. Once payment is successfully processed, the report will be delivered to your email address within 24 hours”

Key Advantages of the Report by MarkNtel Advisors:

Accurate Revenue Projections: The report provides precise revenue estimates for the market and its key subsegments, benefiting both market leaders and new entrants.

Strategic Insights for Stakeholders: By understanding the competitive landscape, stakeholders can strategically position their businesses and develop effective go-to-market strategies.

Comprehensive Market Dynamics Analysis: The report offers valuable insights into the key drivers, restraints, challenges, and opportunities within the market, helping stakeholders make well-informed decisions.

Note: If you need additional information not included in the report, we can customize it to suit your requirements.

Contact Our Analysts for Brochure Requests, Customization, or Any Pre-Purchase Inquiries: https://www.marknteladvisors.com/query/request-customization/amyotrophic-lateral-sclerosis-treatment-market.html

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

More Research Studies:

Global Amyotrophic Lateral Sclerosis Treatment Market - The Global Amyotrophic Lateral Sclerosis Treatment Market size was valued at around USD 0.98 billion in 2024 and is projected to reach USD 0.97 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.1% during the forecast period, i.e., 2025-30.

Global Metagenomics Market - The Global Metagenomics Market was valued at around USD 2.52 billion in 2024 and is projected to reach USD 5.82 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 18.1% during the forecast period, i.e., 2025-30.

Global Medical Equipment Maintenance & Repair Market - The Global Medical Equipment Maintenance & Repair Market was valued at around USD 55 billion in 2024 and is projected to reach USD 92 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.8% during the forecast period, i.e., 2025-30.